Roel Bulthuis

Roel Bulthuis is an Executive Partner of Syncona Investment Management Limited

He brings more than 20 years of life science venture capital, business development and investment banking experience.

In his role at Syncona, Roel supports the investment team and works with portfolio companies, drawing on his significant experience and network across the sector. He is a Board member of Anaveon, iOnctura and Re-Aim.

Previously, Roel was Managing Partner, Head of Investments at Syncona, where he led the investment team. Before joining Syncona, he was Managing Partner and head of healthcare at Inkef Capital, an Amsterdam-based venture capital firm focused on life science investments, where he led the firm's growth into a leading European healthcare VC platform. Earlier, he served as SVP and Managing Director of Merck Group's M-Ventures for almost 10 years, where he played an instrumental role in creating the business and building it into a leading corporate venture capital fund. Prior to his time at M-Ventures, Roel held senior positions in global business development at Merck Serono and was in the investment banking team at Fortis Bank.

Roel holds an MSc in Biopharmaceutical Sciences from Leiden University, Netherlands and an MBA in Finance from the Helsinki School of Economics, Finland. He is a Kauffman Fellow and a Level20 mentor and is highly driven by the development of next generation investor and entrepreneurial talent

Syncona portfolio companies

• iOnctura (Board member)
• Anaveon (Board member)
• Re-Aim Therapeutics (Board member)